How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Elterman, Dean; Gilling, Peter; Roehrborn, Claus; et al. (2021a) Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies. BMJ Surgery, Interventions, and Health Technologies 3: e000090

    2. Gilling P, Barber N, Bidair M et al. (2020) Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. The Canadian Journal of Urology 27: 10072–79

    3. Gilling P, Barber N, Bidair M et al. (2022) Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH. The Canadian Journal of Urology 29: 10960–68

    4. Zorn K, Bidair M, Trainer A et al. (2021) Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass 3: 130‑8

    5. Kaplan-Marans E, Martinez M, Wood A et al. (2022) Aquablation, prostatic urethral lift, and transurethral water vapor therapy: a comparison of device related adverse events in a national registry. Journal of Endourology 36: DOI: 10.1089/end.2021.0455

    6. Helfand BT, Glaser AP, Kasraeian Ali et al. (2021) Men with lower urinary tract symptoms secondary to BPH undergoing Aquablation with very large prostates (> 150 mL). The Canadian Journal of Urology 28: 10884–88

    7. Gloger S, Schueller L, Paulics L et al. (2021) Aquablation with subsequent selective bipolar cauterization versus holmium laser enucleation of the prostate (HoLEP) with regard to perioperative bleeding. The Canadian Journal of Urology 28: 10685–90

    8. Elterman DS, Foller S, Ubrig B et al. (2021b) Focal bladder neck cautery associated with low rate of post-Aquablation bleeding. The Canadian Journal of Urology 28: 10610–13

    9. Elterman D, Bach T, Rijo E et al. (2020) Transfusion rates after 800 Aquablation procedures using various haemostasis methods. BJU International 125: 568–72

    10. Parsons JK, Dahm P, Kohler TS et al. (2020) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Amendment 2020. The Journal of Urology 204: 799–804

    11. Topfer LA, Ryce A, Loshak H (2020) Minimally invasive treatments for lower urinary tract symptoms due to benign prostatic hyperplasia. Ottawa: CADTH; 2020 Feb. (CADTH Issues in Emerging Health Technologies; Issue 182).